 | Athira Pharma, Inc. | |||
| NMS : ATHA || Location: United States | ||||
$1.95+0.03 (+1.3%) |
0.11 M | 1.91 - 2.01 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.044 M |
| March 28, 2024 | 1.009 M |
| March 15, 2024 | 0.979 M |
| Feb. 29, 2024 | 0.784 M |
| Feb. 15, 2024 | 0.650 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.98 | -0.71 | 27.47% |
| 09/30/2023 | -0.83 | -0.87 | -4.78% |
| 06/30/2023 | -0.80 | -0.78 | 2.35% |
| 03/31/2023 | -0.64 | -0.73 | -14.69% |
| 12/31/2022 | -0.68 | -0.53 | 22.45% |
ATHA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 38.327M | Shares Float | 26.921M |
| Short Float | 1.044M | Market Cap | 73.59M |
| Institution ownership | 61.54% | Insider ownership | 2.268% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.95 | Forward EPS | -1.97 |